Surgery Partners, Inc. (SGRY)

14.26USD +0.64% (+0.09)

Over 1M: -8.2%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

14 15 16
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Operating Income: 105.7M Q3 '25 — Net Income: -22.7M Q4 '25 — Operating Income: 110.2M Q4 '25 — Net Income: -15M Q1 '26 — Operating Income: 65.8M Q1 '26 — Net Income: -35.9M Q2 '26 — Operating Income: 102.1M Q2 '26 — Net Income: -15M -30M 0 30M 60M 90M 120M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Operating Income Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.9
SBC / sales 0.44%
Oper. margin 11.4%
OE margin 5.1%
ROIC 5.0%
Accruals -4.3%
FCF margin 5.6%
ROCE 5.1%
Gross margin 22.5%
OCF margin 7.7%
ROA -1.1%
OCF / EBIT 0.67×
ROE -5.3%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

7.0
EV/EBIT 16.4×
EV/OE 36.5×
Div. yield 11.4%
FCF yield 10.0%
P/B 1.1×
EV/Sales 1.9×
P/C 8.6×
EV/GP —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

8.1
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

2.9
ND/EBITDA -0.7
Quick ratio 1.8×
F-score 5.0 pts
Cash / Debt 0.047×
Debt / Eq 2.8×
Debt payback 23.7 yr
Cash runway —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

2.8
Sales CAGR 4Y +10.4%
Sales/sh Y/Y +3.1%
Div. growth +32.6%
Shares change +0.86%
EBIT CAGR +3.1%
EBIT Y/Y +6.1%
Sales Q/Q +2.7%
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.